FARMINGDALE, N.Y., Nov. 5, 2015 /PRNewswire/ — Misonix, Inc. (NASDAQ: MSON), an international surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products for spine surgery, skull based surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery and other surgical applications, today announced

Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone